Introduction:
Healthcare-associated infections (HAIs) remain a significant challenge in healthcare environments, posing risks to patient health, increasing mortality rates, and adding financial burdens to healthcare systems. Conventional disinfection methods, such as chemical cleaners and manual cleaning procedures, often fall short in completely eradicating pathogens from hospital surfaces and equipment. This inadequacy can lead to the spread of infections among patients and healthcare workers. In response, there is growing interest in novel technologies like UV-C light, which offer promise in bolstering infection control efforts within healthcare facilities. (1)
While healthcare workers (HCWs) have long been recognized as vectors for pathogen transmission between patients, recent research highlights the crucial role of contaminated environments in facilitating the spread of infectious agents. (2) High-touch surfaces, in particular, serve as reservoirs for pathogens, enabling secondary transmission through direct contact with patients or indirectly via the hands of HCWs and visitors. This revelation underscores the importance of comprehensive infection control strategies that address environmental contamination to effectively mitigate the risk of HAIs in healthcare settings.
The importance of environmental decontamination, especially in patient-care rooms before admitting subsequent occupants, has grown in recent years. High-touch surfaces require more frequent cleaning and disinfection than minimal touch surfaces to mitigate the risk of pathogen transmission. (3)
While environmental cleaning and disinfection are crucial components of infection control strategies, studies have shown that existing methods may leave surfaces potentially contaminated due to the inability to disrupt biofilms. Recent research on dry-surface biofilms on clinical surfaces highlights the persistence of vegetative bacteria, posing challenges to effective disinfection. (4)
In response, there has been increasing interest in developing more comprehensive environmental disinfection strategies. "No-touch" technologies, such as mobile UV-light disinfection systems, have garnered attention for their advantages, including rapid exposure times and a broad spectrum of action. UV-C irradiation damages microbial cells, inhibiting replication and reducing the risk of infection. (5) Implementing UV-light disinfection systems in hospitals has demonstrated sustained reductions in surface microbial contamination and cross-contamination, as well as a decreased spread of multi-drug resistant bacterial infections. Studies have reported significantly lower environmental contamination rates after UV-C treatment compared to standard cleaning and disinfection protocols. (6)
Combining UV-light disinfection with manual cleaning further reduces bacterial loads on surfaces, offering enhanced protection against infection transmission. Hospitals adopting UV-light disinfection protocols have seen a significant reduction in infection risks associated with environmentally mediated transmission routes. (7)
UV-C light technology operates within the ultraviolet (UV) spectrum, specifically in the wavelength range of 200 to 280 nanometers (nm). (8) This form of UV radiation exhibits potent germicidal properties, enabling it to deactivate a broad spectrum of microorganisms, such as bacteria, viruses, and fungi, by disrupting their DNA and RNA structures. The application of UV-C light technology extends across various healthcare settings, including patient rooms, operating theaters, intensive care units, and ambulatory care facilities. It serves as a versatile tool for disinfecting surfaces, air, and water, effectively reducing the microbial burden and minimizing the risk of healthcare-associated infections.
Efficacy of UV-C Light in Reducing Healthcare-Associated Infections:
In a randomized controlled trial conducted in a hospital setting, researchers compared the effectiveness of UV-C light disinfection with standard cleaning methods alone. (9) The study focused on patient rooms, which are known to harbor various pathogens and serve as potential sources of transmission for HAIs. By implementing UV-C light disinfection in addition to routine cleaning protocols, researchers observed a significant reduction in the transmission of multidrug-resistant organisms (MDROs). MDROs, including bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE), pose a serious threat to patient safety and are notoriously difficult to eradicate through conventional cleaning methods. The use of UV-C light technology proved to be an effective complementary approach in reducing the prevalence of these resilient pathogens within the hospital environment. (10)
Furthermore, UV-C light devices have been increasingly utilized to disinfect high-touch surfaces and equipment in intensive care units (ICUs). These areas are particularly susceptible to contamination due to the frequent contact with patients, medical staff, and visitors. Studies have demonstrated that implementing UV-C light disinfection protocols in ICUs can lead to a decrease in HAIs, including ventilator-associated pneumonia (VAP) and central line-associated bloodstream infections (CLABSIs). VAP and CLABSIs are among the most common HAIs encountered in critical care settings and are associated with significant morbidity and mortality rates. The ability of UV-C light technology to target and eliminate pathogens on high-touch surfaces and medical equipment plays a crucial role in preventing the transmission of infections to vulnerable patients in the ICU.(11)
Challenges and Considerations for Implementation:
Implementation of UV-C light technology in healthcare settings, despite its demonstrated efficacy in reducing healthcare-associated infections (HAIs), presents several challenges and considerations. Chief among these is the initial cost associated with purchasing UV-C devices, which can be substantial and may require significant financial investment from healthcare facilities. (12) Additionally, there is a need for comprehensive staff training to ensure the proper use and operation of UV-C devices, minimizing the risk of safety concerns associated with UV exposure for both patients and healthcare personnel. Logistical challenges such as determining optimal device placement and scheduling device operation to minimize disruption to patient care activities also need to be addressed. (13)
Moreover, integrating UV-C light technology into existing infection control protocols requires careful planning and coordination to ensure its optimal effectiveness without replacing traditional cleaning and disinfection practices. Despite these challenges, the potential benefits of UV-C light technology in enhancing infection prevention efforts and improving patient safety underscore the importance of overcoming these obstacles through strategic planning, training initiatives, and ongoing research and innovation in UV-C technology. (14)
Future Directions and Conclusion:
The use of novel UV-C light technology holds promise for preventing healthcare-associated infections and improving patient safety in healthcare settings. Future research efforts should focus on optimizing UV-C device design and operation, evaluating its long-term effectiveness in reducing HAIs, and addressing practical challenges associated with implementation. (15) By harnessing the potential of UV-C light technology and integrating it into comprehensive infection control strategies, healthcare facilities can enhance their ability to combat HAIs and protect the health and well-being of patients and staff. (16)
Conclusion:
Novel UV-C light technology represents a promising approach for preventing healthcare-associated infections in healthcare settings. Its germicidal properties and ability to effectively inactivate a wide range of microorganisms make it a valuable tool in the fight against HAIs. While challenges exist in implementing UV-C light technology, ongoing research, and collaboration among healthcare providers, researchers, and industry partners can facilitate its successful integration into infection control practices. With continued innovation and investment in UV-C light technology, healthcare facilities can enhance their capacity to protect patients and staff from the risks of HAIs and improve overall patient outcomes.
Reference:
1. Weinstein R.A. Epidemiology and control of nosocomial infections in adult intensive care units. Am. J. Med. 1991;91(Suppl. 3B):179S–184S. doi: 10.1016/0002-9343(91)90366-6.
2. Otter J.A., Yezli S., Salkeld J.A., French G.L. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am. J. Infect. Control. 2013;41:S6–S11. doi: 10.1016/j.ajic.2012.12.004.
3. Dancer S.J. Controlling hospital-acquired infection: Focus on the role of the environment and new technologies for decontamination. Clin. Microbiol. Rev. 2014;27:665–690. doi: 10.1128/CMR.00020-14.
4. Carling P.C., Huang S.S. Improving healthcare environmental cleaning and disinfection. Infect. Control Hosp. Epidemiol. 2013;34:507–513. doi: 10.1086/670222.
5. Liscynesky C., Hines L.P., Smyer J., Hanrahan M., Orellana R.C., Mangino J.E. The Effect of Ultraviolet Light on Clostridium difficile Spore Recovery Versus Bleach Alone. Infect. Control Hosp. Epidemiol. 2017;38:1116–1117. doi: 10.1017/ice.2017.126.
6. Vickery K., Deva A., Jacombs A., Allan J., Valente P., Gosbell I.B. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J. Hosp. Infect. 2012;80:52–55. doi: 10.1016/j.jhin.2011.07.007.
7. Anderson D.J., Chen L.F., Weber D.J., Moehring R.W., Lewis S.S., Triplett P.F., Blocker M., Becherer P., Schwab J.C., Knelson L.P., et al. The benefits of enhanced terminal room (BETR) disinfection study: A prospective, cluster randomized, multicenter, crossover study to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms. Lancet Infect. Dis. 2017;389:805–814. doi: 10.1016/S0140-6736(16)31588-4.
8. Boyce J., Donskey C. Understanding ultraviolet light surface decontamination in hospital rooms: A primer. Infect. Control Hosp. Epidemiol. 2019;18:1030–1035. doi: 10.1017/ice.2019.161.
9. Hodges, J. C., Bilderback, A. L., Bridge, C. M., Wagester, S., Colaianne, B. V., Babiker, A., Minnier, T., Zapf, R. L., Kip, P. L., & Snyder, G. M. (2022). Assessment of the effectiveness of ultraviolet-C disinfection on transmission of hospital-acquired pathogens from prior room occupants. Antimicrobial stewardship & healthcare epidemiology : ASHE, 2(1), e110. https://doi.org/10.1017/ash.2022.254.
10. Yang JH, Wu UI, Tai HM, Sheng WH. Effectiveness of an ultraviolet-C disinfection system for reduction of healthcare-associated pathogens. J Microbiol Immunol Infect. 2019;52(3):487-493. doi:10.1016/j.jmii.2017.08.017.
11. Dong, Z., Zhou, N., Liu, G., & Zhao, L. (2020). Role of pulsed-xenon ultraviolet light in reducing healthcare-associated infections: a systematic review and meta-analysis. Epidemiology and infection, 148, e165. https://doi.org/10.1017/S095026882000148X.
12. Poster, D. L., Miller, C. C., Obeng, Y., Postek, M. T., Cowan, T. E., & Martinello, R. A. (2018). Innovative Approaches to Combat Healthcare-Associated Infections Using Efficacy Standards Developed Through Industry and Federal Collaboration. Proceedings of SPIE--the International Society for Optical Engineering, 10730, 10.1117/12.2500431. https://doi.org/10.1117/12.2500431.
13. Cowan TE, “Healthcare acquired infection (HAIs): a deadly problem that is preventable: UV can help, what’s holding it back?,” Proc. SPIE 10479, 10479A-1 – 10479A-17 (2018) 10.1117/12.2288584.
14. A Critical Review on Ultraviolet Disinfection Systems against COVID-19 Outbreak: Applicability, Validation, and Safety Considerations Milad Raeiszadeh and Babak Adeli ACS Photonics 2020 7 (11), 2941-2951 DOI: 10.1021/acsphotonics.0c01245.
15. Ana Rita Pereira, Daniel F.O. Braga, Mariana Vassal, Inês B. Gomes, Manuel Simões, Ultraviolet C irradiation: A promising approach for the disinfection of public spaces?, Science of The Total Environment, Volume 879, 2023, 163007, ISSN 0048-9697, https://doi.org/10.1016/j.scitotenv.2023.163007.
16. Ramos, C. C. R., Roque, J. L. A., Sarmiento, D. B., Suarez, L. E. G., Sunio, J. T. P., Tabungar, K. I. B., Tengco, G. S. C., Rio, P. C., & Hilario, A. L. (2020). Use of ultraviolet-C in environmental sterilization in hospitals: A systematic review on efficacy and safety. International journal of health sciences, 14(6), 52–65.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation